Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

LA Jolla Pharma (LJPC)

LA Jolla Pharma (LJPC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
La Jolla Pharmaceutical: 2Q Earnings Snapshot

SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Thursday reported a loss of $15.6 million in its second quarter.

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2020 and Highlights Recent Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
Larry Edwards Appointed President and Chief Executive Officer of La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that its Board of Directors has appointed Larry Edwards as President and Chief Executive Officer.

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
TTPH : 2.20 (-3.51%)
SmarTrend Watching for Potential Rebound in Shares of La Jolla Pharm After 4.37% Loss

La Jolla Pharm (NASDAQ:LJPC) traded in a range yesterday that spanned from a low of $4.81 to a high of $5.18. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $4.91...

LJPC : 3.58 (-5.54%)
How La Jolla (LJPC) Stock Stands Out in a Strong Industry

La Jolla (LJPC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

LJPC : 3.58 (-5.54%)
Shares of LJPC Up 50.2% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for La Jolla Pharm (NASDAQ:LJPC) on March 26th, 2020 at $4.96. In approximately 1 month, La Jolla Pharm has returned 50.20% as of today's recent price of $7.45.

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical (LJPC) Reports Q1 Loss, Lags Revenue Estimates

La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of 58.44% and -10.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical: 1Q Earnings Snapshot

SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Monday reported a loss of $8.6 million in its first quarter.

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2020

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company to Provide GIAPREZA(TM) (Angiotensin II) for Emergency Medical Program in Patients with Septic Shock Due to COVID-19 at CHIREC Delta Hospital, Brussels, Belgium

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
Relatively Good Performance Detected in Shares of Novavax Inc in the Biotechnology Industry (NVAX , EPZM , LJPC , FLXN , ESPR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

EPZM : 12.87 (+0.31%)
LJPC : 3.58 (-5.54%)
NVAX : 170.29 (+1.67%)
La Jolla Pharmaceutical Company to Provide GIAPREZA(TM) (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Munster in Germany

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company to Provide GIAPREZA(TM) (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Royal Surrey County Hospital, Guildford, Surrey, United Kingdom

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company to Provide GIAPREZA(TM) (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Frankfurt in Germany

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company to Provide GIAPREZA(TM) (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company to Provide GIAPREZA(TM) (Angiotensin II) in Italy for Compassionate Use in Patients with Septic Shock Associated with COVID-19

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical (LJPC) Reports Q4 Loss, Tops Revenue Estimates

La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of 5.10% and 0.56%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?...

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical: 4Q Earnings Snapshot

SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Monday reported a loss of $25.2 million in its fourth quarter.

LJPC : 3.58 (-5.54%)
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2019

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.58 (-5.54%)

Van Meerten Stock Picks

The 5 Best MidCaps
I wanted to find the 5 Mid Caps that have had the best momentum over the past year so I used Barchart to sort the S&P 400 MidCap Stock Index for the stocks with the highest Weighted Alpha and technical buying signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar